Topics

Companies Related to "Sobi invests 915m Dova hematology portfolio" [Most Relevant Company Matches] RSS

01:30 EST 12th November 2019 | BioPortfolio

Here are the most relevant search results for "Sobi invests 915m Dova hematology portfolio" found in our extensive corporate database of over 50,000 company records.

Showing "Sobi invests 915m Dova hematology portfolio" Companies 1–25 of 1,900+

Extremely Relevant

Sobi

Sobi is an international specialty healthcare company dedicated to rare diseases. Sobi’s mission is to develop and deliver innovative therapies and services to improve the lives of patients. The product portfolio is primarily focused on Haemophilia, Inflammation and Genetic diseases. Sobi also markets a portfolio of specialty and rare disease products ...


Swedish Orphan Biovitrum AB

Sobi is a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives of rare disease patients and their families. Sobi have a diversified and growth-oriented commercial product portfolio. Sobi's key therapeutic areas are Inflammation and Genetics & Metabolism. Sobi's late stage pipeline includes three phase III progra...

Relevant

Michiana Hematology-Oncology,P.C.

Michiana Hematology-Oncology,P.C. is the premier provider of medical oncology, gynecologic oncology and adult hematology services in North-Central Indiana and Southwestern Lower Michigan.Michiana Hematology-Oncology was founded in 1968 by Dr. Thomas Troeger. Following many years of continued growth and success. the medical staff now consists of nine medical oncologists, two gynecologic oncologists...


Sobi Inc.

MachHitech AG

Mach Hitech AG was formed in June 2000 and invests in high-growth companies in the technology sector. After a private placement in July 2000, Mach Hitech AG went public on the Swiss Exchange on September 4. Investment StrategyMach Hitech's strategy is to invest equity in a variety of selected companies in these industries. The funds are mainly invested in 2-4 core companies whose technological an...

Oncology Hematology Care, Inc

Oncology Hematology Care, Inc,we are pleased to announce the opening of our newest clinical office in July 2006! The office is located in the medical arts building on the campus of Mercy Mt. Airy Hospital. Priya Rudolph MD and Kurt Leuenberger MD are currently seeing patients at this location. Both physicians specialize in hematology and medical oncology. In addition to physician consultation, th...

Cambridge Research and Innovation Limited

Cambridge Research and Innovation Limited (CRIL) is a locally based seed capital fund. The CRIL fund invests in new technology based business, including bio businesses, in the UK. CRIL invests from £50,000 to £500,000 at the start up of a company or during the early stages of company growth. In addition to funds CRIL invests significant amounts of its own management time and effort helping to nu...

Streck

Founded in 1971 and headquartered in Omaha, Nebraska, Streck manufactures hematology, chemistry, and immunology products for the clinical laboratory. Recognized worldwide as an innovator of hematology control products, Streck maintains 65% of the world market of hematology controls through a combination of Streck label, private label, and patent licenses.For over 30 years, Streck has been a leadin...

NRD Capital Management, LLC

NRD Capital Management, LLC, founded by Aziz Hashim, invests in brands that offer superior products or services and compelling unit-level economics in order to help them strategically grow through the power of franchising. The fund invests in small to medium-sized franchisors, infusing capital and applying operating expertise to grow brands. NRD has thus f...

HighCape Partners

HighCape Partners is a growth equity fund that invests in commercial-stage life sciences companies. The Company applies decades of combined investment and operational experience to help transform its portfolio companies into sustainable businesses. Aziyo joins Cheetah Medical and TELA Bio as the third company in the HighCape Partners portfolio. For more in...

Paragon Biosciences

For severe and complex diseases, Paragon Biosciences identifies unmet patient needs, invests in novel therapies to treat those medical conditions, launches biopharmaceutical companies to further develop those therapies, and supports these new portfolio companies with early-incubation services. After which, the portfolio companies operate independently as t...

Arboretum Ventures

Arboretum Ventures is an early-stage venture capital firm that invests in private healthcare and life sciences companies. Our areas of focus include the medical device, diagnostic and healthcare service sectors. Located in Ann Arbor, Michigan, Arboretum invests throughout the U.S., with an emphasis on the upper Midwest. We are currently investing from our $24 million first fund.Arboretum takes pri...

3i plc

3i Group plc is a leading international venture capital company. 3i invests in ambitious, growing businesses across the world through 35 investment teams in Europe, Asia Pacific and the USA. It invests in a wide range of opportunities from start-ups to buy-outs and buy-ins, focusing on businesses with high growth potential and strong management.

Connector Medical AB

Connector Medical AB provides medical expertise to the pharmaceutical industry within Hematology/Oncology and is a consulting service. In addition, the company contains a contract research organization (CRO), Connector Clinical Research that performs all aspects of clinical studies for the pharmaceutical industry and which has specialized in Hematology/Oncology.

North Shore Hematology Oncology Associates

Welcome to North Shore Hematology Oncology Associates, PC. For over twenty years, NSHOA has been a community-based private practice providing premium healthcare for our patients using the latest treatment techniques. We are always on the cutting edge of technology and medicine, while ensuring that our patients are treated with dignity and respect. Although we generally only care for adults, we do ...

3i Nordic plc

3i Group plc is a leading international venture capital company. 3i invests in ambitious, growing businesses across the world through 35 investment teams in Europe, Asia Pacific and the USA. It invests in a wide range of opportunities from start-ups to buy-outs and buy-ins, focusing on businesses with high growth potential and strong management.

Intel Capital

Intel Capital invests in innovative startups targeting artificial intelligence, autonomous technology, data center and cloud, 5G, next-generation compute, and a wide range of other disruptive technologies. Since 1991, Intel Capital has invested US$12.5 billion in more than 1,550 companies worldwide, and 670 portfolio companies have gone public or participa...

Hematology-Oncology Associates of CNY

Welcome to the Hematology-Oncology Associates of CNY web site. Our goal is to provide you with useful information about our practice, provide a greater understanding of our services and enrich the partnership we strive to develop with our patients.Founded in 1982, Hematology-Oncology Associates of CNY has been committed to providing the highest level of care to patients with blood disorders and c...

Pharos Capital Group, LLC

Based in Dallas and Nashville, Pharos (www.pharosfunds.com) primarily invests $10 to $30 million in companies seeking later stage equity funding for internal growth, acquisitions, management buyouts or recapitalizations across industry sectors, with particular focus on healthcare and business services. Pharos typically invests in undercapitalized businesse...

Frazier Healthcare Partners

Founded in 1991, Frazier Healthcare Partners is a leading provider of growth capital to healthcare companies. The firm has over $2.4 billion in committed capital under management and has made investments in over 170 healthcare companies, with investment types ranging from company creation and venture capital to growth buyouts and leveraged recapitalization...

Hematology Oncology Assiciates of the Treasure Coast

We are a private physician group specializing in Hematology and Oncology. We provide consultation, treatment, and follow-up care to patients referred to our specialty by the primary care physicians of the Treasure Coast and surrounding communities. As hematology and oncology specialists, we diagnose and treat all types of blood diseases and cancer. We have extensive special training in the treatme...

Tower Hematology Oncology Medical Group

Tower Hematology Oncology Medical Group was formed in 1991 as the result of a merger between two well-established medical oncology practices that had served patients in Los Angeles for more than 10 years. We are a group of diverse cancer specialists that focus on the full spectrum of oncology and hematology problems. By pooling our knowledge, we are able to provide a strong research-based practic...

American Society of Hematology

PER®

Since 1995, PER® has been the leading provider of live, online and print CME activities focusing on oncology and hematology by providing high-quality, evidence-based activities featuring leading experts who focus on the application of practice-changing advances. In 2017, PER® will develop and implement 21 historic annual legacy conferences in the Uni...

Spectrum Pharmaceuticals Inc.

Spectrum Pharmaceuticals is a leading biotechnology company focused on acquiring, developing, and commercializing drug products, with a primary focus in hematology and oncology. Spectrum currently markets six hematology/oncology drugs and has an advanced stage pipeline that has the potential to transform the company. Spectrum's strong track record for in-l...


More From BioPortfolio on "Sobi invests 915m Dova hematology portfolio"

Quick Search

Corporate Database Quicklinks